(Q36722459)

English

Incretins and other peptides in the treatment of diabetes

scientific article published on March 2007

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

title

Incretins and other peptides in the treatment of diabetes (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15 August 2017

Todd JF

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17263764

retrieved

15 August 2017

Bloom SR

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17263764

retrieved

15 August 2017

publication date

1 March 2007

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

17263764

retrieved

15 August 2017

volume

24

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17263764

retrieved

15 August 2017

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17263764

retrieved

15 August 2017

page(s)

223-232

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17263764

retrieved

15 August 2017

cites work

Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.02071.X

retrieved

21 January 2018

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.02071.X

retrieved

21 January 2018

Effects of 1-mo bolus subcutaneous administration of exendin-4 in type 2 diabetes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.02071.X

retrieved

21 January 2018

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.02071.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1464-5491.2006.02071.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17263764

retrieved

15 August 2017

PubMed publication ID

17263764

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17263764

retrieved

15 August 2017

ResearchGate publication ID

6540279

0 references

(Q36722459)

Incretins and other peptides in the treatment of diabetes

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)